Connection

Bircan Kayaaslan to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Bircan Kayaaslan has written about Treatment Outcome.
Bircan Kayaaslan
Connection Strength
0.043
Treatment Outcome
  1. A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients. Clin Res Hepatol Gastroenterol. 2018 02; 42(1):40-47.
    View in: PubMed
    Score: 0.026
  2. Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients. BMC Infect Dis. 2021 May 04; 21(1):411.
    View in: PubMed
    Score: 0.008
  3. Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir. J Infect Public Health. 2021 Mar; 14(3):365-370.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.